Sku |
AAP55398 |
Old sku |
AAPP33270 |
Price |
$99.00 |
Name |
GABARAPL1 Peptide - N-terminal region (AAP55398) |
Purchase info |
To purchase this peptide:
- Copy peptide sku
- Click on this link
- Paste into field "Peptide Sku"
|
Size |
100 ug |
Gene |
GABARAPL1 |
Alias symbols |
APG8L, ATG8, ATG8L, GEC1, ATG8B, APG8-LIKE |
Gene id |
23710 |
Description of target |
GABARAPL1 increases cell-surface expression of kappa-type opioid receptor through facilitating anterograde intracellular trafficking of the receptor. |
Swissprot id |
Q9H0R8 |
Protein accession num |
NP_113600 |
Nucleotide accession num |
NM_031412 |
Protein size |
117 amino acids |
Molecular weight |
14kDa |
Application |
IHC, WB |
Partner proteins |
CALCOCO2,OPRK1,SQSTM1,VDR,CALCOCO2,SQSTM1 |
Quality control |
The peptide is characterized by mass spectroscopy |
Key reference |
Tanida,I., (2006) FEBS J. 273 (11), 2553-2562 |
Description |
This is a synthetic peptide designed for use in combination with anti-GABARAPL1 antibody (Catalog #: ARP55398_P050) made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details. |
Product format |
Lyophilized powder |
Reconstitution and storage |
Add 100ul of sterile PBS. Final peptide concentration is 1 mg/ml in PBS. For longer periods of storage, store at -20C. Avoid repeat freeze-thaw cycles. |
Lead time |
Domestic: within 24 hours delivery International: 3-5 business days |
Protocol |
|
Tips |
See our General FAQ page. |
Availability |
In Stock |